Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

Source:http://linkedlifedata.com/resource/pubmed/id/7477143

N. Engl. J. Med. 1995 Nov 30 333 22 1437-43

Download in:

View as

Triples

General Info

PMID
7477143